Search - tctmd.com

Displaying 41 - 60 of 132

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Aspirin Use Tied to Slower AAA Progression

Todd Neale

December 20, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Features

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Michael O'Riordan

August 14, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Conference News ISC 2023

Tenecteplase Matches Up Well With Alteplase in Acute Stroke: TRACE-2

Todd Neale

February 14, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

Advertisement

Top Endovascular News of 2023

AHA Selects 2023’s Leading Cardiovascular Research

Aspirin Use Tied to Slower AAA Progression

October 2023 News Roundup

September 2023 News Roundup

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

Chaos and Questions: New Public-Access Policies Put Journals in Flux

AHA Scientific Statement Addresses Health Disparities in PAD

February 2023 News Roundup

Only Half of Revascularized PAD Patients Receive GDMT

Tenecteplase Matches Up Well With Alteplase in Acute Stroke: TRACE-2

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Reduction in BP Drives Treatment Preference for Hypertensive Patients

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

What’s Going to Be Hot at ESC 2022?

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

June 2022 News Roundup

April 2022 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content